Cargando…
TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways
Transforming growth factor‐beta (TGF‐β) functions as a potent proliferation inhibitor and apoptosis inducer in the early stages of breast cancer, yet promotes cancer aggressiveness in the advanced stages. The dual effect of TGF‐β on cancer development is known as TGF‐β paradox, and the remarkable fu...
Autores principales: | Zhao, Yuanyuan, Ma, Jing, Fan, Yanling, Wang, Zhiyong, Tian, Ran, Ji, Wei, Zhang, Fei, Niu, Ruifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830653/ https://www.ncbi.nlm.nih.gov/pubmed/29215776 http://dx.doi.org/10.1002/1878-0261.12162 |
Ejemplares similares
-
The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
por: Zhang, Yang, et al.
Publicado: (2019) -
Smad1 promotes colorectal cancer cell migration through Ajuba transactivation
por: Yang, Daming, et al.
Publicado: (2017) -
TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling
por: Hough, Chris, et al.
Publicado: (2012) -
SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways
por: Liu, Lu, et al.
Publicado: (2021) -
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
por: Schlange, Thomas, et al.
Publicado: (2007)